Annual Cash & Cash Equivalents
$8.40 M
0.00%
01 December 2023
Summary:
Cadrenal Therapeutics Common Stock annual cash & cash equivalents is currently $8.40 millionCVKD annual cash & cash equivalents is now at all-time high.CVKD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$4.36 M
-$673.30 K-13.37%
01 September 2024
Summary:
Cadrenal Therapeutics Common Stock quarterly cash and cash equivalents is currently $4.36 million, with the most recent change of -$673.30 thousand (-13.37%) on 01 September 2024. Over the past year, it has dropped by -$4.04 million (-48.06%). CVKD quarterly cash and cash equivalents is now -52.09% below its all-time high of $9.11 million, reached on 01 September 2023.CVKD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CVKD Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -48.1% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
CVKD Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -52.1% | >+9999.0% |
| 5 y | 5 years | at high | >+9999.0% | -52.1% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -52.1% | >+9999.0% |
Cadrenal Therapeutics Common Stock Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.36 M(-13.4%) |
| June 2024 | - | $5.04 M(-23.3%) |
| Mar 2024 | - | $6.57 M(-21.9%) |
| Dec 2023 | $8.40 M | $8.40 M(-7.8%) |
| Sept 2023 | - | $9.11 M(+182.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $3.23 M(-19.8%) |
| Mar 2023 | - | $4.03 M(>+9900.0%) |
| Dec 2022 | $32.60 K | $32.60 K(-68.4%) |
| Sept 2022 | - | $103.10 K(+73.0%) |
| June 2022 | - | $59.60 K |
FAQ
- What is Cadrenal Therapeutics Common Stock annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock quarterly cash and cash equivalents year-on-year change?
What is Cadrenal Therapeutics Common Stock annual cash & cash equivalents?
The current annual cash & cash equivalents of CVKD is $8.40 M
What is the all time high annual cash & cash equivalents for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high annual cash & cash equivalents is $8.40 M
What is Cadrenal Therapeutics Common Stock quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CVKD is $4.36 M
What is the all time high quarterly cash and cash equivalents for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high quarterly cash and cash equivalents is $9.11 M
What is Cadrenal Therapeutics Common Stock quarterly cash and cash equivalents year-on-year change?
Over the past year, CVKD quarterly cash and cash equivalents has changed by -$4.04 M (-48.06%)